Specifically, retatrutide simultaneously activates three incretin and metabolic hormone receptors: GLP-1 (glucagon-like peptide-1) receptor promotes insulin secretion, reduces appetite, and slows gastric emptying [8] [9] GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin release and may support fat metabolism [11] [12] Glucagon receptor preclinical and early clinical data suggest this may increase energy expenditure and promote hepatic fat breakdown, though glucagon receptor agonism can also raise blood glucose levels and the full implications in humans are still being characterised [5] [6] This triple mechanism of action is hypothesised to produce meaningful reductions in body weight by addressing multiple aspects of metabolic dysfunction
Food and Drug Administration (FDA) approved semaglutide sold under the brand name Ozempic mainly for treating type 2 diabetes, so its more likely to be covered when prescribed for that reason
Allow the peptide to dissolve naturally over 1-2 minutes
Severe or persistent vomiting or diarrhea can lead to dangerous dehydration and requires prompt medical attention
The solution: Follow the reconstitution instructions exactly
We found that, after the energy-fixed breakfast, GLP-1 markedly enhanced satiety and fullness compared with placebo (Fig